Corvus Pharmaceuticals, Inc. ($CRVS)
Filing Information
| Accession Number | 0001610717-26-000160 |
|---|---|
| Form Type | 4 |
| Filing Date | May 20, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
6,932
Total Value
$83,453.32
P&L
-1.2% ($962.52)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 18, 2026 | Purchase | 5,000 | $12.05 | $60,250.00 | 1,193,103 | Indirect | By Trust | View Details | |
Director | Common Stock | โ | May 18, 2026 | Purchase | 1,932 | $12.01 | $23,203.32 | 1,195,035 | Indirect | By Trust | View Details |